Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Development of a crosswalk for pain interference measured by the BPI and PROMIS pain interference short form.
Cortical reorganization in multiple sclerosis after intrathecal baclofen therapy.
Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial.
Alemtuzumab in multiple sclerosis: latest evidence and clinical prospects.
XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis
Future treatment approaches to multiple sclerosis.
Clinical trials to clinical use: using vision as a model for multiple sclerosis and beyond.
Raltegravir with optimized background therapy for resistant HIV-1 infection.
Cranberry versus placebo in the prevention of urinary infections in multiple sclerosis: a multicenter, randomized, placebo-controlled, double-blind trial.
[Treatment of relapses of multiple sclerosis (a review)].
Body fluid biomarkers for multiple sclerosis-the long road to clinical application.
Changes in tissue directionality reflect differences in myelin content after demyelination in mice spinal cords.
Multiple sclerosis: A distinct disease course for paediatric multiple sclerosis.
Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis.
Perceptions of health status in multiple sclerosis patients and their doctors.
Effects of a resistance training program and subsequent detraining on muscle strength and muscle power in multiple sclerosis patients.
The potential of microRNAs as biofluid markers of neurodegenerative diseases - a systematic review.
Diagnostic value of 3D fluid attenuated inversion recovery sequence in multiple sclerosis.
Teva and Active Biotech Announce Discontinuation of Higher Doses of Laquinimod in Two Multiple Sclerosis Trials
Therapeutic plasma exchange in neuromyelitis optica: A case series.
Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
Evaluation of retinal nerve fiber layer thickness measured by optical coherence tomography in Moroccan patients with multiple sclerosis.
Hypoxia Inducible Factor-1α in Astrocytes and/or Myeloid Cells Is Not Required for the Development of Autoimmune Demyelinating Disease(,.)
[Clinical study of optic neuritis combined with viral hepatitis].
[The neurodegenerative process in multiple sclerosis and the possible neuroprotective effect of treatment with Β-interferon 1a (avonex).]

Pages